Juan Manuel Mendive

Dr. Juan Manuel Mendive

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2013 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
AHA. P. S. Hungin
A. P. S. Hungin
CMC. Mulligan
C. Mulligan
BPB. Pot
B. Pot
PWP. Whorwell
P. Whorwell
LAL. Agréus
L. Agréus
EGEuropean Society For Primary Care Gastroenterology
European Society For Primary Care Gastroenterology
Evidence suggests that the gut microbiota play an important role in gastrointestinal problems. To give clinicians a practical reference guide on the role of specified probiotics in managing particular lower gastrointestinal symptoms/problems by means of a systematic review-based consensus. Systematic literature searching identified randomised, placebo-controlled trials in adults; evidence for each symptom/problem was graded and statements developed (consensus process; 10-member panel). As results cannot be generalised between different probiotics, individual probiotics were identified for each statement. Thirty seven studies were included; mostly on irritable bowel syndrome [IBS; 19 studies; treatment responder rates: 18-80% (specific probiotics), 5-50% (placebo)] or antibiotic-associated diarrhoea (AAD; 10 studies). Statements with 100% agreement and 'high' evidence levels indicated that: (i) specific probiotics help reduce overall symptom burden and abdominal pain in some IBS patients; (ii) in patients receiving antibiotics/Helicobacter pylori eradication therapy, specified probiotics are helpful as adjuvants to prevent/reduce the duration/intensity of AAD; (iii) probiotics have favourable safety in patients in primary care. Items with 70-100% agreement and 'moderate' evidence were: (i) specific probiotics help relieve overall symptom burden in some patients with diarrhoea-predominant IBS, and reduce bloating/distension and improve bowel movement frequency/consistency in some IBS patients and (ii) with some probiotics, improved symptoms have led to improvement in quality of life. Specified probiotics can provide benefit in IBS and antibiotic-associated diarrhoea; relatively few studies in other indications suggested benefits warranting further research. This study provides practical guidance on which probiotic to select for a specific problem.

1 April 2002 in International Journal for Quality in Health Care
Verified
Journal Article
Open access
PDF file
MWMichel Wensing
Michel Wensing
PVPeter Vedsted
Peter Vedsted
JKJanko Kersnik
Janko Kersnik
WPWim Peersman
Wim Peersman
AKAnja Klingenberg
Anja Klingenberg
RGRichard Grol
Richard Grol
Objective. To identify associations between the characteristics of general practitioners and practices, and patients’ evaluations of the availability of general practice. Design. Written surveys completed by patients. Setting. General practice care in nine European countries: Denmark, Germany, The Netherlands, Norway, UK, Belgium (Flanders and Wallonia), Switzerland, Slovenia, and Spain. Study participants. 15 996 adults patients consecutively visiting the general practitioner (response rates per country varied between 47 and 89%). Main measures. The Europep instrument to assess patients’ evaluations of five aspects of the availability of general practice care: (1) getting an appointment, (2) getting through on the phone, (3) being able to speak to the practitioner on the telephone, (4) waiting time in the waiting room, and (5) providing quick services for urgent health problems. Each general practitioner recorded age, sex, number of years in the practice, number of practitioners and other care providers in the practice, and urbanization level of the practice. Results. Patients’ more positive evaluations were associated with fewer general practitioners in the practice, except for quick services for urgent health problems (range of conditional overall odds ratios, 1.69–2.02). In addition, a number of significant unconditional overall odds ratios were found, particularly those related to the number of general practitioners’ working hours and the number of care providers in the practice. None of the associations was found consistently in all countries. Conclusion. Patients favour small practices and full-time general practitioners, which contradicts developments in general practice in many countries. Policy makers should consider how the tensions between patients’ views and organizational developments can be solved.

1 August 2012 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
AFAnna Fernández
Anna Fernández
JMJuan Manuel Mendive
Juan Manuel Mendive
LSLuis Salvador-Carulla
Luis Salvador-Carulla
MRMaria Rubio-Valera
Maria Rubio-Valera
Juan V. LucianoJuan V. Luciano
Juan V. Luciano
TIthe DASMAP investigators
the DASMAP investigators
Background: Within the ICD and DSM review processes there is growing debate on the future classification and status of adjustment disorders, even though evidence on this clinical entity is scant, particularly outside specialised care.Aims: To estimate the prevalence of adjustment disorders in primary care; to explore whether there are differences between primary care patients with adjustment disorders and those with other mental disorders; and to describe the recognition and treatment of adjustment disorders by general practitioners (GPs).Method: Participants were drawn from a cross-sectional survey of a representative sample of 3815 patients from 77 primary healthcare centres in Catalonia. The prevalence of current adjustment disorders and subtypes were assessed face to face using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Multilevel logistic regressions were conducted to assess differences between adjustment disorders and other mental disorders. Recognition and treatment of adjustment disorders by GPs were assessed through a review of patients' computerised clinical histories.Results: The prevalence of adjustment disorders was 2.94%. Patients with adjustment disorders had higher mental quality-of-life scores than patients with major depressive disorder but lower than patients without mental disorder. Self-perceived stress was also higher in adjustment disorders compared with those with anxiety disorders and those without mental disorder. Recognition of adjustment disorders by GPs was low: only 2 of the 110 cases identified using the SCID-I were detected by the GP. Among those with adjustment disorders, 37% had at least one psychotropic prescription.Conclusions: Adjustment disorder shows a distinct profile as an intermediate category between no mental disorder and affective disorders (depression and anxiety disorders).

12 August 2022 in Clinical Nutrition
Verified
Journal Article
Open access
SBStephan C. Bischoff
Stephan C. Bischoff
RBRocco Barazzoni
Rocco Barazzoni
Luca BusettoLuca Busetto
Luca Busetto
MCMarjo J.E. Campmans-Kuijpers
Marjo J.E. Campmans-Kuijpers
VCVincenzo Cardinale
Vincenzo Cardinale
CCCristina Cuerda
Cristina Cuerda
Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean GI patients. The present guideline addresses this question according to current knowledge and evidence. The objective of the guideline is to give advice to all professionals working in the field of gastroenterology care including physicians, surgeons, dietitians and others how to handle patients with GI disease and obesity. The present guideline was developed according to the standard operating procedure for ESPEN guidelines, following the Scottish Intercollegiate Guidelines Network (SIGN) grading system (A, B, 0, and good practice point (GPP)). The procedure included an online voting (Delphi) and a final consensus conference. In 100 recommendations (3x A, 33x B, 24x 0, 40x GPP, all with a consensus grade of 90% or more) care of GI patients with obesity - including sarcopenic obesity - is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially fatty liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician. The present guideline offers for the first time evidence-based advice how to care for patients with chronic GI diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.

12 August 2022 in United European Gastroenterology Journal
Verified
Journal Article
Open access
SBStephan C. Bischoff
Stephan C. Bischoff
RBRocco Barazzoni
Rocco Barazzoni
Luca BusettoLuca Busetto
Luca Busetto
MCMarjo J.E. Campmans-Kuijpers
Marjo J.E. Campmans-Kuijpers
VCVincenzo Cardinale
Vincenzo Cardinale
CCCristina Cuerda
Cristina Cuerda
Background: Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean GI patients. The present guideline addresses this question according to current knowledge and evidence.Objective: The objective of the guideline is to give advice to all professionals working in the field of gastroenterology care including physicians, surgeons, dietitians and others how to handle patients with GI disease and obesity.Methods: The present guideline was developed according to the standard operating procedure for European Society for Clinical Nutrition and Metabolism guidelines, following the Scottish Intercollegiate Guidelines Network grading system (A, B, 0, and good practice point [GPP]). The procedure included an online voting (Delphi) and a final consensus conference.Results: In 100 recommendations (3x A, 33x B, 24x 0, 40x GPP, all with a consensus grade of 90% or more) care of GI patients with obesity – including sarcopenic obesity – is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially fatty liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician.Conclusion: The present guideline offers for the first time evidence‐based advice how to care for patients with chronic GI diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.

10 April 2023 in Clinical Nutrition
Verified
Journal Article
Closed access
SBStephan C. Bischoff
Stephan C. Bischoff
JOJohann Ockenga
Johann Ockenga
AEAhad Eshraghian
Ahad Eshraghian
RBRocco Barazzoni
Rocco Barazzoni
Luca BusettoLuca Busetto
Luca Busetto
CCCristina Cuerda
Cristina Cuerda